93606 ⎘
Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups , X being a hetero atom, Y being any atom; Y being a hetero atom X or Y being nitrogen atoms
Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle
#2BICYCLOPENTANE DERIVATIVES
#3Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle
#4G-ALPHA-S INHIBITORS AND USES THEREOF
#5AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#6AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#7Cleavable lipids
#8UREA DERIVATIVE
#9HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF
#10UREA DERIVATIVE
#11Cleavable lipids
#12Histone acetyltransferase activators and uses thereof
#13Urea derivative
#14Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#15Cleavable lipids
#16Amino mercaptan compound and preparation method therefor and use thereof in protection against radiation
#17Prodrugs of phenolic TRPV1 agonists
#18Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#19Cleavable lipids
#20Cleavable Lipids
#21SYNTHESIS AND USE OF AMINO LIPIDS
#22OMEGA-3 ANALOGUES
#23Use of DDX3X inhibitors for the treatment of pneumovirus infections
#24Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#25N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
#26Amorphous form of a thiocolchicine derivative
#27Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#28Epoxyeicosatrienoic acid analogs and methods of making and using the same
#29Salty taste-enhancing agent and manufacturing method therefor, and salty taste-enhancing method
#30Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#31N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
#32Cleavable lipids
#33Epoxyeicosatrienoic acid analogs and methods of making and using the same
#34Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#35Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
#36Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
#37Histone acetyltransferase activators and uses thereof
#38Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#39Histone deacetylase inhibitors and methods of use thereof
#40Method and synthesis
#41Facially amphiphilic polymers and oligomers and uses thereof
#42Process for synthesis of amino-methyl tetralin derivatives
#432-adamantylurea derivatives as selective 11β-HSD1 inhibitors
#44Compositions and methods for the treatment of disease associated with TRP-P8 expression
#45Antagonists of prostaglandin Dreceptors
#46Partially fluorinated ureas and amides
#47COMPOUND, COMPOSITION AND USES THEREOF
#48Antagonists of Prostaglandin D2 Receptors
#49Tetrahydro-naphthalene derivatives
#50Antagonists of Prostaglandin D2 Receptors
#51FLUORINATED ACRYLATE COMPOSITIONS
#52Histone deacetylase inhibitors and methods of use thereof
#53Inhibitors for the soluble epoxide hydrolase
#54Process for synthesis of amino-methyl tetralin derivatives
#55Imaging 18F or 11C-labelled alkylthiophenyl guanidines
#56METHOD OF TREATING NEUROBLASTOMA
#57Anti-malarial compounds
#58Antagonists of prostaglandin D2 receptors
#592-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
#60Benzoylurea Compounds and Use Thereof
#61Histone deacetylase inhibitors and methods of use thereof
#62Glucagon Antagonists/Inverse Agonists
#63Guanidine derivatives as inhibitors of DDAH
#64Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#65Partially fluorinated ureas and amides
#66N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
#67Tetrahydro-naphthalene derivatives
#68N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
#69Therapeutic fluoroethylcyano guanidines
#70N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
#71BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS
#72Facially amphiphilic polymers and oligomers and uses thereof
#73Alpha-helical mimetics
#74Novel Biphenyl Compounds And Their Use
#75N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
#76C-linked cyclic antagonists of P2Yreceptor useful in the treatment of thrombotic conditions
#77Inhibitors for the soluble epoxide hydrolase
#78Novel methoxybenzamibe compounds for use in mch receptor related disorders
#79New 3-aryl propionic acid derivatives and analogs
#80Cyclic derivatives as modulators of chemokine receptors activity
#81Tetrahydro-naphthalene derivatives
#82Methods of using substituted tetralins and indanes
#83Inhibitors of histone deacetylase
#84Facially amphiphilic polymers and oligomers and uses thereof
#853-Aryl-2-hydroxypropionic acid derivative I
#86Compounds for inhibiting insulin secretion and methods related thereto
#87Inhibitors of histone deacetylase
#88Imaging compounds
#89Positive allosteric modulators of the nicotinic acetylcholine receptor
#90Thiol-modified hyaluronan
#91Glucagon antagonists/inverse agonists
#92Glucagon antagonists/inverse agonists
#93Compositions and methods for the treatment of disease associated with Trp-p8 expression
#94Histone deacetylase inhibitors and methods of use thereof
#95Histone deacetylase inhibitors and methods of use thereof